with a known single parathyroid gland such as patients in whom hyperparathyroidism has recurred following Background. Tertiary hyperparathyroidism continues to cause significant morbidity in patients with chronic a previous surgical subtotal parathyroidectomy and who are unsuitable for further surgery. renal failure. This is frequently resistant to medical management and may ultimately require a surgical Key words: chemical parathyroidectomy; percutanparathyroidectomy. Recent studies have reported upon eous fine needle ethanol injection; tertiary hyperthe technique of percutaneous ethanol ablation for parathyroidism both primary and tertiary hyperparathyroidism. In this study we report on a 5 year experience using ethanol injection and compare the results with surgical parathyroidectomy.
Introduction
Methods. A prospective study in 39 patients with tertiary hyperparathyroidism, 25 were dialysis depend-
The pathogenesis of secondary hyperparathyroidism is ent and 14 had a functioning renal allograft. Twentybeing better understood as the interaction of calcium, two patients underwent percutaneous fine needle ethphosphate, and calcitriol upon their specific receptors anol injection (PFNEI ) and 17 underwent surgical in the kidney, gut, and parathyroid glands are being parathyroidectomy.
elucidated [1] [2] [3] . Control of serum phosphate using Results. A >30% reduction in intact parathyroid hordietary restriction, intestinal phosphate binders and mone (iPTH ) was achieved in 11 of 22 patients underdialysis, together with the use of 1,25 dihydroxyvitamin going PFNEI after a mean of 1.8±1.4 injections per D3 may prevent the development of hyperparathyroidgland. In four patients, symptomatic hyperparathyism in patients with end-stage renal failure [4] [5] . roidism recurred and they required further PFNEI or Despite these measures, there may be continued hypersurgical parathyroidectomy at 17, 28, 46, and 48 plasia of parathyroid glands, and a review of the months later. There was no significant reduction in European dialysis registry in 1989 revealed that iPTH in 11 patients following PFNEI after a mean of 10-15% of haemodialysis patients required a parathy-2.5±1.3 injections per gland. They all required a roidectomy after 10 years dialysis therapy [6 ] . subsequent surgical parathyroidectomy for symptoSurgical parathyroidectomy is not without complicamatic hyperparathyroidism. Four patients developed a tion. Peri-operative morbidity including permanent laryngeal nerve palsy following PFNEI, two of which laryngeal nerve palsy and symptomatic hypocalcaemia were permanent. Seventeen patients underwent successmay occur [7, 8] . Total parathyroidectomy may result ful surgical parathyroidectomy as a primary procedure.
in adynamic bone, whilst sub-total parathyroidectomy, Conclusion. Whilst PFNEI is successful in primary introduced to avoid the consequences of total parathyhyperparathyroidism, when typically only one adenroidectomy, exposes the patient to the risk of recuroma is present, the effectiveness of PFNEI is unpredictrence requiring further surgery [9] . able and the long term results are poor compared with Percutaneous fine needle ethanol injection (PFNEI ) those of surgical parathyroidectomy in tertiary hyperof the parathyroid glands was first reported by Solbiati parathyroidism. The procedure is not without comet al. in 1985 [10] . This technique was developed plications and makes subsequent surgery more difficult.
following the observation that remission of hyperparaTherefore it can only be recommended for patients thyroidism occurred in several patients following fine needle aspiration cytology, used for confirmation of 
Subjects and methods
assess the blood supply pre-and at 30 min post-injection. All patients suffered transient discomfort at the time of the In a 5 year period from August 1991 to August 1996, 39 injection, but the procedures were performed on an outpatients, 17 women and 22 men mean age 48.6±12.1 years, patient basis and all patients were able to return home. with severe hyperparathyroidism were assessed for PFNEI Serum biochemistry was checked twice weekly for 1 month of their parathyroid glands. There were 25 dialysis patients following the injection. If serum iPTH had not declined by (19 haemodialysis, 6 CAPD), and 14 patients with a func->30% after one month, patients were referred for further tioning renal allograft. The causes of end-stage renal failure PFNEI. Patients were referred for parathyroidectomy if, were: chronic glomerulonephritis (12), chronic interstitial after a maximum of five injections, there was no significant nephritis±obstruction (9), congenital and polycystic (6), reduction in serum iPTH or they refused further injections. hypertension and renovascular (5), diabetes mellitus (2), and Patients with a >30% reduction in serum iPTH but levels uncertain aetiology (5) . There were four patients with recur->200 pg/ml, were treated with adjunct vitamin D therapy. rent hyperparathyroidism following a previous sub-total Calcitriol or alfacalcidol was given orally, as a daily or twice parathyroidectomy.
weekly pulsed regimen; doses were adjusted according to Patients were considered for intervention if they fulfilled serum standard calcium and iPTH. one or more of the following criteria: the failure to suppress serum PTH to <750 pg/ml with optimal medical manageParathyroidectomy ment (including pulsed calcitriol therapy), persistent hypercalcaemia (standard calcium >2.9 mmol/l ), or symptomatic Seventeen patients were considered unsuitable for PFNEI; bone pain. six patients had more than two glands detected on ultraPatients were selected for PFNEI or surgery according to sound, four had no parathyroid glands detected, and in three the findings of their neck ultrasound. Patients were considpatients the glands identified were too small to inject. The ered suitable for PFNEI if one or two glands >5 mm in presence of a multi-nodular goitre excluded two patients. diameter were identified. Glands <5 mm in diameter were Anatomical difficulties excluded one patient and one refused not injected because the tip of the needle could not be to undergo PFNEI after an aspiration biopsy, considering it accurately localised to the centre of the gland, with a too painful. All were referred for surgery with a total or subconsequent risk of extravasation of ethanol to surrounding total parathyroidectomy performed according to operative tissue. In patients with one or two glands >5 mm but with findings. additional glands <5 mm, the larger glands were injected and the patients treated with adjunct vitamin D therapy.
Patients with three or four glands >5 mm were not offered Biochemistry PFNEI generally unless they were considered a high surgical risk or refused surgery. Absolute contra-indications to Serum calcium and total alkaline phosphatase (total ALP) PFNEI were the presence of a multi-nodular goitre, deep were measured by autoanalyser (Hitachi autoanalyser localisation of the gland, or close proximity to a major vessel. Boehringer Mannheim). Standard calcium was calculated A serum aluminium was obtained on all patients and a from the equation of Payne: standard calcium= low dose desferrioxamine (DFO) test (5 mg DFO/kg) was Ca+(40−albumin)×0.025 [17] . The iPTH was measured performed in those with concentration persistently by radioimmunoassay (Nichols Institute Diagnostic Ltd) >1.8 mmol/l [16 ]. Two patients had positive DFO tests, i.e. (normocalcaemic range 10-55 pg/ml ). an increase in serum aluminium >2.0 mmol/l, and underwent right iliac crest bone biopsy. Histology revealed severe hyperparathyroid bone disease in both biopsies associated with Statistical analysis severe aluminium deposition in one and mild deposition in the other. Both patients were given DFO chelation therapy All results are expressed as mean±SD. Statistical analysis was performed using an ASTUTE statistical calculator comuntil repeat DFO tests were negative. The patient with severe deposition was investigated with a repeat bone biopsy which puter program. Mann-Whitney and T-test were employed as appropriate. A probability of <0.05 was considered statistic-Repeat PFNEI was successful in one of two patients ally significant.
but not attempted in the other two patients due to the presence of more than two glands. These three patients underwent successful sub-total parathyroidectomy.
Results
Histology revealed predominantly diffuse hyperplasia in two patients and nodular hyperplasia in a third. Patients were classified as follows: Group A, 11 patients There were areas of dense fibrosis in the glands which who underwent PFNEI with a >30% reduction in had previously undergone PFNEI ( Figure 1 ). serum iPTH; group B, 11 patients who had a <30% reduction in serum iPTH, and who remained symptomatic despite repeated PFNEI and medical therapy, and therefore surgical parathyroidectomy was per-Group B formed; group C, 17 patients who were considered unsuitable for PFNEI and were referred directly for In these 11 patients, there was no significant change in surgical parathyroidectomy.
serum iPTH following a mean of 2.5±1.3 injections The ultrasonographic findings and pre-treatment per gland. They all subsequently required a surgical serum biochemistry for the 22 patients who underwent parathyroidectomy. Table 3 shows the serum biochem-PFNEI, and the preoperative biochemistry of the 17 istry pre-and post-ethanol injection and pre-and postpatients in whom a surgical parathyroidectomy was parathyroidectomy. There was no significant difference performed, are shown in Table 1 . The number of glands in serum biochemistry pre-PFNEI or pre-parathyand the total volume of parathyroid tissue was greater roidectomy. Four patients underwent total, and seven in groups B than A, although this did not reach underwent sub-total parathyroidectomy. There was a statistical significance (P=0.08 and 0.06, respectively). highly significant reduction in serum standard calcium, Subsequent parathyroidectomy in those patients in iPTH, and total ALP following parathyroidectomy. group B resulted in the removal of an extra gland in Histology revealed five patients with predominantly two patients and two glands in six patients, which had diffuse hyperplasia, two with mixed diffuse and nodular not been detected on the initial ultrasound. There was hyperplasia and four patients with predominantly no statistically significant difference in the serum iPTH, nodular hyperplasia. There were areas of dense fibrosis standard calcium, or total ALP between groups A, B, in the glands that had undergone previous PFNEI. and C.
Group A Group C Table 2 shows the changes in the serum biochemistry Seventeen patients considered unsuitable for PFNEI of the 11 patients who had a >30% reduction in serum were referred for surgical parathyroidectomy, five of iPTH following a mean of 1.8±1.4 injections per whom underwent a total, and 12 underwent sub-total gland, which was associated with a significant decline parathyroidectomy. Table 4 shows the changes in the in total ALP. In nine of these patients, there was a serum biochemistry following parathyroidectomy with >50% reduction in serum iPTH, (746±324 to highly significant reductions in standard calcium, 237±198 pg/ml ). Mean serum iPTH remained signiiPTH, and total ALP. Histology revealed six patients ficantly lower than pre-treatment levels for 6 months with predominantly diffuse hyperplasia, eight with following treatment. Symptomatic hyperparathyroidmixed diffuse and nodular hyperplasia, and three ism recurred in four patients, who required further intervention at 17, 28, 46, and 68 months, respectively. patients with predominantly nodular hyperplasia. Group A, patients with a >30% reduction in iPTH following PFNEI. Group B, patients with no reduction in iPTH following PFNEI. Group C, patients undergoing surgical parathyroidectomy as a primary procedure. In those patients requiring subsequent parathyroidec-
Colour Doppler blood flow mapping
tomy, local dissection was extremely difficult in the areas of previous ethanol injection due to dense local Blood flow mapping was undertaken to assess tissue fibrosis presumably from local ethanol extravasation. destruction. A marked reduction in blood flow was One patient who had suffered permanent laryngeal recorded in all glands following treatment (Figure 2) . nerve palsy following PFNEI and needed a surgical In those patients who subsequently required surgical parathyroidectomy subsequently, developed severe parathyroidectomy, histology revealed significant fibstridor post-operation, requiring re-intubation and rosis in the glands treated previously. A reduction in subsequent transfer to the Intensive Care Unit for 48 h Doppler blood flow following injection confirmed observation. There were no reported complications tissue destruction but was unable to distinguish with the patients who underwent primary surgical between those patients who would have responded to parathyroidectomy. PFNEI and those who would not.
Complications Discussion
In this study, we found 11 of 22 (50%) patients had a All patients described a transient local burning sensation as the ethanol was injected into the parathyroid >30% reduction in serum iPTH after an average of 1.8±1. The greatest success rate appears in those studies with the shortest time intervals between injections. Karstrup et al. in a prospective study of patients with primary hyperparathyroidism injected 14 patients at weekly intervals and another 18 patients at monthly intervals [12] . Hyperparathyroidism was controlled in 11 (79%) patients injected weekly compared with 12 (66%) patients injected monthly. In a further study of primary hyperparathyroidism, seven patients were injected at 24 h intervals to a single parathyroid adenoma [11] . Serum iPTH declined to normal in six of seven patients following two or three injections. The only treatment failure had two parathyroid glands removed at parathyroidectomy, one of which had not been detected by ultrasound. In patients with secondary hyperparathyroidism, Kitaoka et al. reported a high success rate when patients were injected at weekly intervals until their serum iPTH was <200 pg/ml [14] . In our study, we aimed to perform subsequent injections, if required, within 1 month, although there were patients in whom this time interval was greater.
The volume of ethanol injected does not appear to alter success rate of this procedure, but large volumes may increase the risk of collateral damage. Despite being injected into the centre of the gland, ethanol does not diffuse uniformly and will follow the line of least resistance, resulting in extravasation from the gland and damage to adjacent tissue. Histology of the parathyroid tissue removed from patients in whom PFNEI was not successful revealed large fibrous bands with compartments of parathyroid tissue. Once compartmentalisation has occurred, it is unlikely that subsequently the needle will puncture directly, or ethanol diffuse into, all of the pockets of remaining parathyroid tissue. The greatest reported success rates have been obtained with a modified needle which promotes diffusion throughout the gland, with injections repeated at weekly intervals [14] .
In this study, PFNEI failed to suppress the iPTH in 50% of the patients. Colour Doppler blood flow mapping revealed a significant reduction in the blood supply in the glands injected of both responders and non responders ( Figure 2 ). The failure in these patients was probably not of the technique to destroy the gland injected but the inability to detect with ultrasound all the hyperplastic glands present, resulting in poor patient selection. Subsequent parathyroidectomy in those patients in group B resulted in the removal of an extra gland in two patients and two glands in six patients, which had not been detected on the initial ultrasound. In the four patients in Group C referred for parathyroidectomy because no discernible gland The best results in this study were obtained in 8: 993-1004 patients who had previously undergone subtotal para- 
